RecruitingNot ApplicableNCT06446817

Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL

Multicentric Clinical Investigation to Determine Safety and Efficacy of a Hydrophobic Acrylic Multifocal Intraocular Lens

Sponsor

Cutting Edge SAS

Enrollment

57 participants

Start Date

Dec 19, 2024

Study Type

INTERVENTIONAL

Conditions

Cataract

Summary

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called LuxGood IOL and a medical device called LuxHighAdd IOL for people with cataract. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.